✦ LIBER ✦

Single-Agent Epidermal Growth Factor Receptor Inhibitor Gefitinib for the Treatment of Patients with Advanced Non—Small-Cell Lung Cancer and Poor Performance Status

✍ Scribed by Nagla Abdel Karim; Salma Musaad; Abdul Rahman Jazieh

Book ID: 114412074
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 92 KB
Volume: 9
Category: Article
ISSN: 1525-7304
DOI: 10.1016/s1525-7304(11)70860-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer

✍ Chia-Chi Lin; Chih-Hsin Yang 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 156 KB

Single-agent gefitinib with concurrent r

Single-agent gefitinib with concurrent radiotherapy for locally advanced non-small cell lung cancer harboring mutations of the epidermal growth factor receptor

✍ Okamoto, Isamu; Takahashi, Toshiaki; Okamoto, Hiroaki; Nakagawa, Kazuhiko; Watan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 141 KB

The impact of epidermal growth factor re

The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer

✍ Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Sh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 403 KB 👁 2 views

## Abstract We investigated the relationships between genetic factors and clinical outcome in Japanese non‐small‐cell lung cancer (NSCLC) patients treated with gefitinib. Ninety‐eight NSCLC patients who had been treated with gefitinib, were screened for mutations in epidermal growth factor receptor

Gefitinib as first-line treatment for pa

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence

✍ Gridelli, C.; De Marinis, F.; Di Maio, M.; Cortinovis, D.; Cappuzzo, F.; Mok, T. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Single-Agent Gefitinib in Patients with

Single-Agent Gefitinib in Patients with Untreated Advanced Non–Small-Cell Lung Cancer and Poor Performance Status: A Minnie Pearl Cancer Research Network Phase II Trial

✍ David R. Spigel; John D. Hainsworth; Emily R. Burkett; Howard A. Burris; Denise 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 519 KB

OP3 Cost-effectiveness of epidermal grow

OP3 Cost-effectiveness of epidermal growth-factor receptor mutation testing and first-line treatment with gefitinib for advanced non-small-cell lung cancer

✍ G. de Lima Lopes; J. Segel; D. Tan; Y. Do; T. Mok; E. Finkelstein 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB